Business

Curaleaf Takes Equity Stake in New Jersey’s Boone Town Provisions

mm
Published
Add MyCannabis.com to your preferred sources on Google

Curaleaf Holdings, based in Stamford, Connecticut, announced on November 2, 2026 that it has acquired an equity stake and certain operating rights in Boone Town Provisions, a dispensary at 677 Myrtle Ave. in Boonton, New Jersey. The acquisition expands Curaleaf’s retail footprint to four dispensaries in the state and 191 nationwide, and the company said it expects the storefront to be immediately accretive to its New Jersey business. The release states the transaction’s expected completion remains subject to closing conditions and regulatory approvals.

“Boone Town Provisions is one of the top-performing dispensaries in New Jersey,” said Boris Jordan, Curaleaf’s chairman and CEO. “We have acquired our interest in the dispensary at an attractive valuation that aligns with our disciplined approach to capital allocation. The acquisition strengthens our position in New Jersey, allows us to increase our vertical position, adds a proven, high-performing location to our retail footprint, and expands access to our brands for more customers in the state.”

The Boonton Store

Opened in July 2024, the 6,400-square-foot store sits on a busy stretch of Myrtle Avenue with few dispensaries nearby, according to Curaleaf’s release. Myrtle Avenue carries Route 202 through Boonton, and the dispensary’s website places it one minute off I-287 in Morris County, within reach of surrounding towns including Parsippany, Rockaway, Denville, Montville, Mountain Lakes and Fairfield.

Boone Town Provisions describes itself as a locally owned and operated adult-use recreational dispensary. Anyone 21 or older with a government-issued photo ID can shop, and no New Jersey medical cannabis card is required. Its menu spans flower, vapes, pre-rolls, edibles, CBD, concentrates, tinctures and topicals, and the store carries New Jersey brands such as Mudd Brothers alongside Fernway and Cookies. The store takes cash and cards, keeps an on-site ATM and offers self-service ordering kiosks, and its site lists discounts of 15% for veterans and senior citizens and 10% for medical cardholders, first responders and cannabis industry workers. According to its website, it opens Monday through Saturday from 9 a.m. to 10 p.m. and Sunday from 10 a.m. to 8 p.m.

Curaleaf’s New Jersey Footprint

Boone Town Provisions complements Curaleaf’s three other New Jersey dispensaries, located in Bellmawr, Bordentown and Edgewater Park.

Curaleaf has served New Jersey’s medical community since opening its Bellmawr dispensary in 2015, the company said in a June 2021 announcement. Its Edgewater Park store opened that month as the company’s second New Jersey dispensary and 107th nationwide, a 7,640-square-foot location at 4237 Route 130 South that at the time served patients with a valid medical card. In the same release, Curaleaf said its second New Jersey cultivation facility, in Winslow, had completed its first harvest and become fully operational, tripling the company’s cultivation capabilities in the state to serve both the existing medical market and the forthcoming adult-use market.

mm

Ava Morales is an AI-generated research agent for MyCannabis.com, covering U.S. cannabis regulation with a focus on state-by-state legalization, medical programs, and consumer compliance. Her work helps readers navigate the fragmented legal landscape governing cannabis access, possession, and use across the United States.

With a structured and explanatory approach, Ava tracks legislative changes, ballot initiatives, and regulatory guidance affecting both medical and recreational cannabis markets. She emphasizes clarity over speculation, distinguishing clearly between enacted law, proposed reforms, and local enforcement realities so readers understand what is permitted in their jurisdiction today.

Articles authored by Ava Morales are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, neutrality, and responsible reporting on cannabis laws in regulated U.S. markets.